HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells

Cancer Biology and Therapy

Volumn 3, Issue 6, 2004, Pages 568-572

  Chu, Micheline C ^a   Selam, F Belgin ^a   Taylor, Hugh S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Estradiol; HOXA10; p53; Tamoxifen

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; HOX PROTEIN; MATRIGEL; MESSENGER RNA; PROTEIN P53; TAMOXIFEN; COLLAGEN; DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; HOXA10 PROTEIN, HUMAN; LAMININ; PROTEOGLYCAN;

ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; CONTROLLED STUDY; DNA FLANKING REGION; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; NORTHERN BLOTTING; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADULT; BREAST; BREAST TUMOR; CANCER INVASION; CELL CULTURE; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; FEMALE; GENETICS; METABOLISM; PATHOLOGY;

ADULT; BREAST; BREAST NEOPLASMS; COLLAGEN; DNA-BINDING PROTEINS; DRUG COMBINATIONS; ESTRADIOL; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; LAMININ; NEOPLASM INVASIVENESS; PROTEOGLYCANS; RECEPTORS, ESTROGEN; RNA, MESSENGER; TAMOXIFEN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 12244276678     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.6.848     Document Type: Article

References (33)

1. Brekelmans CT. Risk factors and risk reduction of breast and ovarian cancer. Curr Opin Obstet Gynecol 2003; 15:63-8.
2. Rossouw JE, Andersen GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-33.
3. Kinsinger LS, Harris R, Woolf SH, Sox HC, Lohr KN. Chemoprevention of breast cancer: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137:59-69.
4. Fischer B, Constantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90:1371-88.
5. Taylor HS, Arici A, Olive D, Igarashi P. HOXA10 is Expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest 1998; 101:1379-84.
6. Taylor HS, Igarashi P, Olive DL, Arici A. Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium. J Clin Endocrinol Metab1999; 84:1129-35.
7. Chau MY, Pando S, Taylor HS. HOXA11 silencing and endogenous HOXA11 antisense RNA in the uterine endometrium J Clin Endocrinol Metab 2000; 87:2674-80.
8. Block K, Kardana A, Igarashi P, Taylor HS. In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system. FASEB J 2000; 14:1101-8.
9. Lewis EB. The 1991 Albert Lasker Medical Awards. Clusters of master control genes regulate the development of higher organisms. JAMA 1992; 267:1524-31.
10. Ivins S, Pemberton K, Guidez F, Howell L, Krumlauf R, Zelent A. Regulation of Hoxb2 by APL-associated PLZF protein. Oncogene 2003; 22:3685-97.
11. Owens BM, Hawley RG. HOX and nonHOX homeobox genes in leukemic hematopoiesis. Stem Cells 2002; 20:364-79.
12. Emerling BM, Bonifas J, Kratz CP, Donovan S, Taylor BR, Green ED, et al. MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia. Oncogene 2002; 18:4849-54.
13. Knoepfler PS, Sykes DB, Pasillas M, Kamps M. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation. Oncogene 2001; 20:5440-8.
14. Rozovskaia T, Feinstein E, Mor O, Foa R, Blechman J, Nakamura T, et al. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4:11) abnormality. Oncogene 2001; 20:874-8.
15. Thorsteinsdottir U, Kroon E, Jerome L, Blasi F, Sauvageau G. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol Cell Biol 2001; 21:224-34.
16. Friedmann Y, Daniel CA, Strickland P, et al. Hox genes in normal and neoplastic mouse mammary gland. Cancer Research 1994; 54:5981-5.
17. Cantile M, Pettinato G, Procino A, Feliciello A, Cindolo L, Cillo C. In vivo expression of the whole HOX gene network in human breast cancer. Eur J Cancer 2003; 39:257-64.
18. Zhang X, Zhu T, Chen Y, Mertani HC, Lee KO, Lobie PE. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem 2003; 278:7580-90.
19. Prives C, Hall PA. The p53 pathway. J Pathol 1999; 187:112-6.
20. Reisman D, Greenberg M, Rotter V. Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1. Proc Natl Acad Sci USA 1988; 85:5146-50.
21. Deschamps J, Meijlink F. Mammalian homeobox genes in normal development and neoplasia. Crit Rev Oncog 1992; 3:171-3.
22. Soule HD, Vazquez A, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973; 51:1409-16.
23. Janiak M, Hashmi HR, Janowska-Wieczorek A. Use of the matrigel-based assay to measure the invasiveness of leukemic cells. Exp Hematol 1994; 22:559-65.
24. Abate-Shen C. Deregulated homeobox gene expression in cancer: Cause or consequence? Nat Rev Cancer 2002; 2:777-85.
25. Cillo C, Cantile M, Faiella A, Boncinelli E. Homeobox genes in normal and malignant cells. J Cell Physio 2001; 188:161-9.
26. Cillo C, Faiella A, Cantile M, Boncinelli E. Homeobox genes and cancer. Exp Cell Res 1999; 248:1-9.
27. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. Embo J 1998; 17:3714-25.
28. Maulbecker, CC, Gruss P. The oncogenic potential of deregulated homeobox genes. Cell Growth Differ 1993; 4:431-41.
29. Schnabel CA, Jacobs Y, Cleary ML. HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis. Oncogene 2000; 19:608-16.
30. Soubeyran P, Haglund K, Garcia S, Barth BU, Iovanna J, Dikic I. Homeobox gene Cdx1 regulates Ras, Rho and PI3 kinase pathways leading to transformation and tumorigenesis of intestinal epithelial cells. Oncogene 2001; 20:4180-7.
31. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, et al. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 2000; 405:974-8.
32. Reisman D, Loging WT. Transcriptional regulation of the p53 tumor suppressor gene. Semin Cancer Biol 1998; 8:317-24.
33. Celetti A, Barba P, Cillo C, Rotoli B, Boncinelli E, Magli MC. Characteristic patterns of HOX gene expression in different types of human leukemia. Int J Cancer 1993; 53:237-44.